March 14th, 2008
An allergic reaction to the cancer drug cetuximab has been found.
Sometimes the reaction includes anaphylaxis, a life-threatening condition characterized by a drop in blood pressure, fainting, difficulty breathing, and wheezing.
Now researchers funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have discovered that specific pre-existing antibodies […]
By Gloria Gamat -- 2 comments
April 25th, 2007
When all other treatment options for colorectal cancer have been exhausted to no significant effect, cetuximab is the effective treatment option.
Such were the suggestion confirmed by a research study recently presented at the 2007 Annual Meeting of the American Association for Cancer Research
According to Derek Jonker, M.D., assistant professor at the University of Ottawa and […]
By Gloria Gamat -- 3 comments
April 12th, 2007
Metastases – the process of cancer spreading to other parts of the body - is a scary word in cancer.
A research team led by Dr. Joan Massagué from the Memorial Sloan-Kettering Cancer Center (New York, US) has demonstrated a way to stop breast cancer metastasis by either switching off the genes involved in the process […]
By Gloria Gamat -- 0 comments
January 22nd, 2007
Preliminary findings of a new study designed by researchers at the University of Maryland Medical Center found that adding the chemotherapy drug cetuximab (brand name Erbitux) to radiation therapy and chemotherapy may help some patients with head and neck cancer to live longer.
According to Mohan Suntharalingam, M.D., lead author of the study and a radiation […]
By Gloria Gamat -- 0 comments
Recent Comments